Clinical Trial Update: Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

This clinical trial record notes a completed Phase 3, controlled study of MK-0431/ONO-5435 in patients with Type 2 Diabetes Mellitus, sponsored by Ono Pharmaceu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-0431/ONO-5435

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED